Note of Clarification of Data in the Paper Titled X-Ray Repair Cross-Complementing Group 1 Codon 399 Polymorphism and Lung Cancer Risk: An Updated Meta-Analysis

Tumor Biology - United States
doi 10.1007/s13277-015-3384-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Lack of Correlation Between X-Ray Repair Cross-Complementing Group 1 Gene Polymorphisms and the Susceptibility to Colorectal Cancer in a Malaysian Cohort

European Journal of Cancer Prevention
OncologyEpidemiologyCancer ResearchPublic HealthEnvironmentalOccupational Health
2017English

Association of N-Acetyltransferase 1 Polymorphism and Bladder Cancer Risk: An Updated Meta-Analysis and Trial Sequential Analysis

International Journal of Biological Markers
OncologyCancer ResearchClinical BiochemistryForensic MedicineMedicinePathology
2017English

Association Between lncRNA H19 Rs217727 Polymorphism and the Risk of Cancer: An Updated Meta-Analysis

BMC Medical Genetics
Genetics
2019English

Association of Angiotensin ІІ Type 1 Receptor Gene A1166C Polymorphism With Cancer Risk: An Updated Meta-Analysis

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2019English

Polymorphism in IGFBP3 Gene Is Associated With Prostate Cancer Risk: An Updated Meta-Analysis

OncoTargets and Therapy
OncologyPharmacology
2016English

No Association Between XRCC1 Gene Arg194Trp Polymorphism and Risk of Lung Cancer: Evidence Based on an Updated Cumulative Meta-Analysis

Tumor Biology
MedicineCancer Research
2014English

Association Between an Indel Polymorphism Within the Distal Promoter of EGLN2 and Cancer Risk: An Updated Meta‐analysis

Molecular genetics & genomic medicine
GeneticsMolecular Biology
2019English

FASL Rs763110 Polymorphism Contributes to Cancer Risk: An Updated Meta-Analysis Involving 43,295 Subjects

PLoS ONE
Multidisciplinary
2013English

Excision Repair Cross-Complementing Group-1 (ERCC1) Induction Kinetics and Polymorphism Are Markers of Inferior Outcome in Patients With Colorectal Cancer Treated With Oxaliplatin

Oncotarget
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy